![](/img/cover-not-exists.png)
Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis: results of a phase 1, randomized, open-label trial
Doyle, M. K., Rahman, M. U., Frederick, B., Birbara, C. A., de Vries, D., Toedter, G., Wu, X., Chen, D., Ranganath, V. K., Westerman, M. E., Furst, D. E.Volume:
52
Language:
english
Journal:
Rheumatology
DOI:
10.1093/rheumatology/kes381
Date:
July, 2013
File:
PDF, 165 KB
english, 2013